ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Large Increase in Short Interest

ProtoKinetix, Incorporated (OTCMKTS:PKTX) saw a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 107,454 shares, an increase of ∞ from the June 30th total of 0 shares. Based on an average trading volume of 210,818 shares, the short-interest ratio is currently 0.5 days.

ProtoKinetix Stock Performance

OTCMKTS:PKTX remained flat at $0.01 during mid-day trading on Friday. 10,000 shares of the company’s stock traded hands, compared to its average volume of 150,164. The business has a 50-day simple moving average of $0.01 and a 200 day simple moving average of $0.01. ProtoKinetix has a 52-week low of $0.00 and a 52-week high of $0.01.

ProtoKinetix Company Profile

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.